# FDA Inspection 820792 - Huntsville Reproductive Medicine P.C. - February 22, 2013

Source: https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/d6554a6a-4479-45a5-a38c-62fd16f6f8e7
Source feed: FDA_Inspections

> FDA Inspection 820792 for Huntsville Reproductive Medicine P.C. on February 22, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 820792
- Company Name: Huntsville Reproductive Medicine P.C.
- Inspection Date: 2013-02-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1187473 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/acc4a08a-8eff-41ff-a2b8-27e44b8e32bf)
- [FDA Inspection 1187473 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/74477588-777e-43b2-a8a2-610a2e72289b)
- [FDA Inspection 1187473 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/c7e4916c-da0d-43c1-9883-df9cb617c23c)
- [FDA Inspection 1058611 - 2018-07-12](https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/70493326-6797-4860-a64e-d359c5c502cb)
- [FDA Inspection 1058611 - 2018-07-12](https://www.keypedia.com/records/fda_inspections/huntsville-reproductive-medicine-pc/57e448c4-6be4-452a-a1b5-0f9c39272e15)

Company: https://www.keypedia.com/companies/huntsville-reproductive-medicine-pc/5970f9ce-acd7-45bf-8979-c8fdf8911e3e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d